Bicuspid aortic valve: A synergistic factor for aortic dilation and dissection in Marfan syndrome?;Válvula aórtica bicúspide: ¿un factor sinérgico para dilatación y disección aórtica en el síndrome de Marfan?

Revista de Investigacion Clinica

Volumn 62, Issue 1, 2010, Pages 39-43

  Amezcua Guerra, Luis ^a   Santiago, Carlos ^a   Espínola Zavaleta, Nilda ^a   Pineda, Carlos ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

Author keywords

Aortic dissection; Bicuspid aortic valve; Marfan syndrome

Indexed keywords

ADOLESCENT; ADULT; AORTA DILATATION; AORTA DISSECTION; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTERIAL WALL THICKENING; ARTERY DILATATION; ARTICLE; BICUSPID AORTIC VALVE; CARDIOVASCULAR RISK; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; MEXICO; PREVALENCE; PROGNOSIS; SCHOOL CHILD; STUDENT T TEST;

ADOLESCENT; ADULT; ANEURYSM, DISSECTING; AORTA; AORTIC ANEURYSM; AORTIC VALVE; CHILD; COHORT STUDIES; COMORBIDITY; DATABASES, FACTUAL; DILATATION, PATHOLOGIC; DISEASE SUSCEPTIBILITY; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MARFAN SYNDROME; MEXICO; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77952194260     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Januzzi JL, Isselbacher EM, Fattori R, et al. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol 2004; 43: 665-669 (Pubitemid 38229542)
2. Ince H, Nienaber CA. Etiology, pathogenesis and management of thoracic aortic aneurysm. Nat Clin Pract Cardiovasc Med 2007; 4: 418-427 (Pubitemid 47180326)
3. The Universal Mutation Database [updated 2007 July 20]. Available from: http://www.umd.necker.fr/disease.html.
4. Bonderman D, Gharehbaghi-Schnell E, Wollenek G, et al. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation 1999; 99: 2138-2143 (Pubitemid 29196798)
5. Nataatmadja M, West M, West J, et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 2003; 108(Suppl. II): II329-II334. (Pubitemid 37099977)
6. Fedak PWM, de Sa MPL, Verma S, et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg 2003; 126: 797-806. (Pubitemid 37151966)
7. Gershoni-Baruch R, Moor EV, Enat R. Marfan syndrome associated with bicuspid aortic valve, premature aging, and primary hypogonadism. Am J Med Genet 1990; 37: 169-172 (Pubitemid 20346209)
8. Porciani MC, Attanasio M, Lepri V, et al. Prevalence of cardiovascular manifestations in Marfan syndrome. Ital Heart J Suppl 2004; 5: 647-652
9. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62: 417-426 (Pubitemid 26131122)
10. Movahed MR, Hepner AD, Ahmadi-Kashani M. Echocardiographic prevalence of bicuspid aortic valve in the population. Heart Lung Circ 2006; 15: 297-299 (Pubitemid 44426254)
11. Faivre L, Collod-Beroud G, Loeys BL, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 2007; 81: 454-466 (Pubitemid 47330205)
12. Espínola-Zavaleta N, Casanova-Garcés JM, Muñoz-Castellanos L, et al. Echocardiometric evaluation of cardiovascular abnormalities in Marfan syndrome. Arch Cardiol Mex 2005; 75: 133-140
13. Sariola H, Viljanen T, Luosto R. Histological pattern and changes in extracellular matrix in aortic dissections. J Clin Pathol 1986; 39: 1074-1081 (Pubitemid 17175060)